IFNG and colonic neoplasm: In comparison to low doses of DFMO and Rosuvastatin alone treatments, the combination treatments of these drugs increased the expressions of perforin and IFN-γ in NKG2D receptor positive NK cells in colon tumors (Fig. 3).